In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
A conversation with Upperton’s Director of Pharmaceutical Sciences, Laura Mason about the upcoming trends she sees emerging ...
Total New Medical Entities by Pharma Company 1999-2018. Modified from "R&D efficiency of leading pharmaceutical companies – A 20-year analysis" Last week I published an article on the three academic ...